MedPath

Synnovation Therapeutics, Inc.

Synnovation Therapeutics, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2021-01-01
Employees
11
Market Cap
-
Website
http://www.synnovationtx.com

SNV4818 in Participants With Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Advanced Solid Tumors
Interventions
First Posted Date
2024-12-17
Last Posted Date
2025-05-15
Lead Sponsor
Pikavation Therapeutics, Inc.
Target Recruit Count
140
Registration Number
NCT06736704
Locations
🇦🇺

Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia

🇺🇸

Sarah Cannon Research Institute, Nashville, Tennessee, United States

🇺🇸

The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States

and more 5 locations

SNV1521 in Participants with Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Advanced Solid Tumor
Interventions
First Posted Date
2024-01-24
Last Posted Date
2025-03-13
Lead Sponsor
Synnovation Therapeutics, Inc.
Target Recruit Count
200
Registration Number
NCT06220864
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

🇺🇸

Thomas Jefferson University, Philadelphia, Pennsylvania, United States

🇦🇺

Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

and more 6 locations
© Copyright 2025. All Rights Reserved by MedPath